Clinical observation on combination therapy of acupuncture and chinese herbal medicine in treating vocal cord nodule

2000 ◽  
Vol 6 (1) ◽  
pp. 56-57
Author(s):  
Qiang Xie ◽  
Shurong Yang
Keyword(s):  
Herbal Medicine ◽  
Combination Therapy ◽  
Vocal Cord ◽  
Chinese Herbal Medicine ◽  
Clinical Observation ◽  
Chinese Herbal

scholarly journals Clinical observation on chinese herbal medicine in treatment of long-term insomnia

2000 ◽  
Vol 6 (2) ◽  
Author(s):  
David Wang ◽  
Charlie Xue ◽  
Noel Lim ◽  
Woei-Jia Jiang ◽  
Jennifer R Jamison
Keyword(s):  
Herbal Medicine ◽  
Chinese Herbal Medicine ◽  
Clinical Observation ◽  
Chinese Herbal

scholarly journals Chinese herbal medicine combination therapy for patients with steroid-dependent ulcerative colitis

Medicine ◽  
2020 ◽  
Vol 99 (16) ◽  
pp. e19729
Author(s):  
Qiaobo Ye ◽  
Zhipeng Hu ◽  
Maoyi Yang ◽  
Kaihua Qin ◽  
Yingguang Zhou
Keyword(s):  
Ulcerative Colitis ◽  
Herbal Medicine ◽  
Combination Therapy ◽  
Chinese Herbal Medicine ◽  
Chinese Herbal ◽  
Steroid Dependent

scholarly journals Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 12 ◽  
Author(s):  
Xu-Qin Du ◽  
Li-Peng Shi ◽  
Wen-Fu Cao ◽  
Zhi-Wei Chen ◽  
Biao Zuo ◽  
...  
Keyword(s):  
Herbal Medicine ◽  
Combination Therapy ◽  
Symptom Score ◽  
Chinese Herbal Medicine ◽  
Conventional Therapy ◽  
Clinical Cure ◽  
Clinical Cure Rate ◽  
Cochrane Library ◽  
Cure Rate ◽  
Chinese Herbal

Background: The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread to become a global emergency since December 2019. Chinese herbal medicine plays an important role in the treatment of COVID-19. Chinese herbal medicine honeysuckle is an extremely used traditional edible and medicinal herb. Many trials suggest that honeysuckle has obtained a good curative effect for COVID-19; however, no systematic evaluation on the clinical efficacy of honeysuckle in the treatment of COVID-19 is reported. This study aimed to evaluate the efficacy and safety of Chinese herbal medicine honeysuckle in the treatment of COVID-19.Methods: Seven electronic databases (PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure, China Science and Technology Journal Database, Wanfang Database, and China Biology Medicine) were searched to identify randomized controlled trials (RCTs) of honeysuckle for adult patients (aged ≥ 18 years) with COVID-19. The Cochrane Risk of Bias Tool was applied to assess the methodological quality of trials. Review Manager 5.3 software was used for data analysis.Results: Overall, nine RCTs involving 1,286 patients were enrolled. Our meta-analyses found that combination therapy of honeysuckle and conventional therapy was more effective than conventional therapy alone in lung computed tomography (CT) [relative risk (RR) = 1.24, 95% confidence interval (95%CI) (1.12, 1.37), P < 0.0001], clinical cure rate [RR = 1.21, 95%CI (1.12, 1.31), P < 0.00001], and rate of conversion to severe cases [RR = 0.50, 95%CI (0.33, 0.76), P = 0.001]. Besides, combination therapy can improve the symptom score of fever, cough reduction rate, symptom score of cough, and inflammatory biomarkers (white blood cell (WBC) count; C-reactive protein (CRP)) (P < 0.05).Conclusion: Honeysuckle combined with conventional therapy may be beneficial for the treatment of COVID-19 in improving lung CT, clinical cure rate, clinical symptoms, and laboratory indicators and reducing the rate of conversion to severe cases. Besides, combination therapy did not increase adverse drug events. More high-quality RCTs are needed in the future.

scholarly journals An Overview of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Formula Granules

2019 ◽  
Vol 2019 ◽  
pp. 1-12
Author(s):  
Mei Han ◽  
Lily Lai ◽  
Xin-xue Li ◽  
Nan-qi Zhao ◽  
Jing Li ◽  
...  
Keyword(s):  
Herbal Medicine ◽  
Combination Therapy ◽  
Adverse Events ◽  
Positive Result ◽  
Chinese Herbal Medicine ◽  
Conventional Therapy ◽  
Hbv Dna ◽  
Cochrane Library ◽  
Controlled Trials ◽  
Chinese Herbal

Objective. To summarize the characteristics and the outcomes of the Randomized Placebo-Controlled Trials of Chinese Herbal Medicine Granules manufactured by China Resources Sanjiu Pharmaceutical Co., Ltd. Methods. Databases including China National Knowledge Infrastructure, VIP, Wanfang, PubMed, Cochrane Library, and clinicaltrials.gov were searched in March 2018 for relevant randomized controlled trials (RCTs). Two reviewers independently screened for and selected studies, extracted data, and checked data extraction. Methodological quality was evaluated using the Cochrane Risk of Bias tool. For the outcome, the characteristics of the study, the cure rate, the effectiveness rate, and advert events were described with a method of bibliometrics. Also, we performed meta-analysis only if there were ≥2 studies treated by the same intervention and evaluated by the same outcome. Results. A total of 40 placebo-controlled RCTs treated for 17 diseases were included in our analysis involving 4,632 patients. 16 of 19 studies treated by CHM granules only showed positive result in patients with HBV, HCV, fever, depression, nonalcoholic fatty liver disease, AIDS, and asthma while negative result was shown in patients with migraine. 17 of 21 studies treated by combination therapy against conventional therapy showed positive result in patients with HBV, herpes simplex keratitis, COPD, liver cirrhotic ascites, Parkinson’s disease, and diabetic peripheral neuropathy while negative result was shown in patients with myasthenia gravis, angina pectoris, and depression. The pooled result cannot demonstrate that the notifying kidney formula granules had the superior effect with placebo on the clearance of serum HBV DNA and HBeAg in HBV carriers with a RR (and the 95% CI) of 2.97 [0.74,11.91] and 1.99 [0.93,4.29], respectively. But, the CHM granules can reduce within-group HBV DNA levels by more than 2 lgIU/ml; the RR (and 95% CI) was 4.64 [2.89,7.45]. Qizhu granules had a significant effect on clearance of HCV RNA with a RR (and 95% CI) of 6.26 [2.16,18.16]. And, the heat-clearing and detoxifying formula granules were superior to placebo in resolution of cold symptom among patients with fever with a RR and 95% CI of 2.58 [1.40,4.74]. Based on the conventional therapy, the pooled result demonstrated that the Regulating liver formula granules were superior to placebo on the clearance of serum HBeAg in chronic hepatitis B patients with a RR (and the 95% CI) of 1.73 [1.30,2.31]. The EeChen decoction granules were superior to placebo in COPD patients with a RR (and the 95% CI) of 1.13 [1.06,1.22]. 28 of the 40 studies reported adverse events. There were 51 adverse events in CHM formula granules group or combination group (n=2,483) and 26 in control group (n=2,122) totally. Most of the adverse symptoms spontaneously resolved after completing the courses of treatment and the other adverse symptoms improved after symptomatic treatment. Conclusion. 16 of 19 studies treated by CHM granules only showed positive result in 7 diseases and negative result in 1 disease. 17 of 21 studies treated by combination therapy against conventional therapy showed positive result in 6 diseases and negative result in 3 diseases. However, both the absolute and relative effectiveness of CHM formula granules compared with placebo need to be considered clinically.

Sign in / Sign up

Export Citation Format

Share Document